Summary of project PR000844

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000844. The data can be accessed directly via it's Project DOI: 10.21228/M8KQ4X This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

Project ID: PR000844
Project DOI:doi: 10.21228/M8KQ4X
Project Title:Modeling the metabolic interplay between a parasitic worm and its bacterial endosymbiont allows the identification of novel drug targets
Project Summary:The filarial nematode Brugia malayi represents a leading cause of disability in the developing world, causing lymphatic filariasis in nearly 40 million people. Currently available drugs are not well-suited to mass drug administration efforts, so new treatments are urgently required. One potential vulnerability is the endosymbiotic bacteria Wolbachia—present in many filariae—which is vital to the worm. Genome scale metabolic networks have been used to study prokaryotes and protists and have proven valuable in identifying therapeutic targets, but only recently have been applied to eukaryotic organisms. Here, we present iDC625, the first compartmentalized metabolic model of a parasitic worm. We used this model to show how metabolic pathway usage allows the worm to adapt to different environments, and predict a set of 99 reactions essential to the survival of B. malayi. We validated three of those reactions with drug tests and demonstrated novel antifilarial properties for all three compounds.
Institute:NYU Langone Health
Last Name:Jones
First Name:Drew
Address:430 E29th Street, WT635A
Email:drew.jones@nyulangone.org
Phone:6465012054

Summary of all studies in project PR000844

Study IDStudy TitleSpeciesInstituteAnalysis
(* : Contains Untargted data)
Release
Date
VersionSamplesDownload
(* : Contains raw data)
ST001258 Modeling the metabolic interplay between a parasitic worm and its bacterial endosymbiont allows the identification of novel drug targets Brugia malayi The Hospital for Sick Children; NYU Langone Health MS 2019-10-11 1 17 Uploaded data (5.8G)*
  logo